Emma Eckernäs
PhD researcher in pharmacokinetics and pharmacodynamics at the University of Gothenburg
Key Impact
She is a key contributor to modern DMT research, especially on its pharmacokinetics, pharmacodynamics, EEG effects, and dose optimization for psychedelic studies.
Background & Research
Emma Eckernäs completed doctoral research on the pharmacokinetics and pharmacodynamics of DMT at the University of Gothenburg’s Institute of Neuroscience and Physiology. Her work has focused on how DMT exposure relates to subjective psychedelic intensity, EEG changes, metabolism, and infusion dosing strategies, often in collaboration with psychedelic researchers at Imperial College London. She has also coauthored clinical and neuroimaging studies on extended DMT administration and network-level brain effects.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →